 |
|
|
November10, 2003
Torii Pharmaceutical Co., Ltd. |
|
Notice Concerning Acquisition of the Company's Own Shares
Through ToSTNet-2 |
|
| Torii Pharmaceutical Co., Ltd. announced the decision on the
method of acquisition of its own shares in accordance with the Japanese Commercial
Code Article 210, with details as follows. |
| 1. |
Method of Acquisition |
| |
Shares will be purchased at the Tokyo Stock Exchange at 8:45
on the morning of November 10, 2003 at the closing price of ¥1,718 per share
as of today, November11, 2003. Transactions (closing price transaction) will be
made through ToSTNeT-2, and shall not be made by other trading systems or at another
time. The purchase order will be valid only at the time designated for transactions. |
| 2. |
Contents of Acquisition |
| |
|
|
|
| (1) |
Type of shares to be acquired: |
common stock |
| (2) |
Total number of shares to be acquired: |
600,000 shares |
| (Note1) |
This number is final. Depending on market fluctuations and other
factors, a part or all of the transaction may not be performed. |
| (Note2) |
The purchase is to be made by selling orders corresponding to
the number of shares planned to be acquired. |
|
| 3. |
Announcement of Results of Acquisition |
| |
A related announcement will be made after
the conclusion of transactions at 8:45 on the morning of July 28, 2003.
(Reference)
|
|
|
| (1) |
Resolution at the ordinary general meeting of shareholders
held on June 24, 2003 |
Type of shares to be acquired:
Number of share to be acquired:
Total value of shares acquired: |
common stock
1,000,000 shares (maximum)
¥1,800,000,000 (maximum) |
| (2) |
Progress as of November 10, 2003 |
| |
Total number of shares acquired:
Total value of shares acquired: |
0 shares
¥0 |
|
|
|
|
| |
|
|
|
|
